Pharmaceutical News

RSS

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

Pacific Beach BioSciences, Inc. today reported that it has granted non-exclusive rights to a large pharmaceutical company for the use of one of its anti-fungal compounds required for the manufacturing of a clinical stage product.

9 Dec 2009

Alternative, fast and safe process for producing large quantities of effective flu vaccines

A shortage of flu vaccines may soon become a problem of the past. Researcher Manon Cox has developed an alternative process for producing large quantities of safe and effective vaccines at twice to four times the usual speed. The process is based on using cells in bioreactors instead of fertilised chicken's eggs, which have a limited availability.

9 Dec 2009

Drug makers attract scrutiny over cost and ads, but may benefit from overhaul

Drug makers came under scrutiny after the AARP published research recently showing their wholesale prices had increased by an average of 9.3 percent during the past year, offsetting the value of rebates the industry promised as part of a health care overhaul to help seniors pay for drugs.

9 Dec 2009

USPTO grants CyDex Pharmaceuticals patent for Captisol

CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled “Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof.” This patent, along with other previously issued technology patents, will provide broader protection for CyDex’s Captisol® technology until 2028.

9 Dec 2009

Misuse of blood thinners in dialysis patients reported

Reuters/ABC News reports on research published in the Journal of the American Medical Association that examined the misuse of two blood thinners - Lovenox and Integrilin - in "about 20 percent of kidney dialysis patients who undergo a procedure to open a blocked artery [who] are given the wrong blood clot medicine, increasing the chances of significant bleeding, researchers said Tuesday.

9 Dec 2009

Newly created line of skin care products based on ISCO’s proprietary Parthenogenic Stem Cells

Lifeline Skin Care, Inc, a wholly owned subsidiary of International Stem Cell Corporation, announced today that it has retained the services of a highly experienced expert in the skin care industry, Raulee Marcus, to help design a marketing program for its newly created line of skin care products based on ISCO’s proprietary Parthenogenic Stem Cells.

9 Dec 2009

Protalix Biotherapeutics completes NDA submission for taliglucerase alfa

Protalix Biotherapeutics, Inc. today announced the completion of its New Drug Application (NDA) submission with the U.S. Food and Drug Administration (FDA) for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD) for the potential treatment of Gaucher’s disease.

9 Dec 2009

Particle Sciences expands High Potency Compound handling capabilities

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has further expanded their High Potency Compound (HPC) handling capabilities through a unique relationship with IES Engineers.

9 Dec 2009

AHS annual meeting focuses on myeloma, says IMF

The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians— says a large number of abstracts – nearly a quarter of the presentations submitted this year to the annual meeting of the American Society of Hematology (ASH) were for myeloma, with one being presented at the prestigious plenary session.

9 Dec 2009

Report on the community-acquired pneumonia drug market

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the patent expiries of three blockbuster antibiotics -- levofloxacin, moxifloxacin and piperacillin/tazobactam -- will be the primary factors contributing to a decline of more than 15 percent in the community-acquired pneumonia drug market though 2018.

9 Dec 2009

New drug designed to stop cancer from spreading by preventing mitosis

TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world's first clinical trials site for a new drug designed to halt cancer cell division.

9 Dec 2009

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

California Stem Cell, Inc. (CSC) and Families of Spinal Muscular Atrophy (FSMA) announced today that the FDA has granted orphan drug designation to MOTORGRAFT™, a stem cell-derived motor neuron product, for the treatment of Spinal Muscular Atrophy (SMA).

9 Dec 2009

European markets for Parkinson's disease therapeutics to reach $2.28 billion in 2015

The Parkinson's disease therapeutics market in 2008 amounted to over $1 billion in the European Union (EU), which includes total sales of carbidopa/levodopa, dopamine agonists, MAO-B inhibitors, COMT inhibitors and anticholinergics used for disease symptom relief.

9 Dec 2009

Depression drug TC-5214 earns USF its most lucrative patent royalties to date

A depression drug created and patented by a team of University of South Florida researchers is at the center of major deal between global pharmaceutical company AstraZeneca PLC and Targacept, Inc., earning the university its potentially most lucrative patent royalties to date.

9 Dec 2009

Nutrient-rich diet is the best way to stay healthy and reduce risk of chronic diseases

While supplements can help some people meet their nutrition needs, eating a wide variety of nutrient-rich foods is the best way for most people to obtain the nutrients they need to be healthy and reduce their risk of chronic disease, according to a newly updated position paper titled "Nutrient Supplementation" from the American Dietetic Association.

9 Dec 2009

Pharming Group NV's pre-BLA meeting with the FDA for Rhucin

Biotech company Pharming Group NV today confirmed its interactions in a pre-BLA meeting with the US Food and Drug Administration (FDA) on a proposed marketing application (BLA or Biologics License Application) to obtain marketing approval for Rhucin for the treatment of acute attacks of HAE (Hereditary Angioedema).

9 Dec 2009

Antithrombotic medication may increase risk of bleeding in dialysis patients undergoing PCI procedure

Approximately 20 percent of dialysis patients undergoing a percutaneous coronary intervention (PCI; procedure such as angioplasty) are given an antithrombotic medication they should not receive, which may increase their risk for in-hospital bleeding, according to a study in the December 9 issue of JAMA.

9 Dec 2009

Most antidepressant medications raise serotonin levels and miss key target of clinical depression

A key brain protein called monoamine oxidase A (MAO-A) - is highly elevated during clinical depression yet is unaffected by treatment with commonly used antidepressants, according to an important study published today in the Archives of General Psychiatry. The study has important implications for our understanding of why antidepressants don't always work.

9 Dec 2009

Physicians trust the safety and efficacy of H1N1 vaccine

A recent visit to the pediatric H1N1 vaccine clinic at a major Chicago medical center showed a surprising clientele - most parents bringing their children for vaccination were also medical professionals.

9 Dec 2009

Researchers find striking disparities in HPV vaccine awareness among low-income population

Results of two separate studies show lower rates of HPV vaccination in low-income populations, and identify vaccination barriers and tailored interventions that may help to increase HPV vaccine uptake rates.

9 Dec 2009

Pharmaceutical News

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

Alternative, fast and safe process for producing large quantities of effective flu vaccines

Drug makers attract scrutiny over cost and ads, but may benefit from overhaul

USPTO grants CyDex Pharmaceuticals patent for Captisol

Misuse of blood thinners in dialysis patients reported

Newly created line of skin care products based on ISCO’s proprietary Parthenogenic Stem Cells

Protalix Biotherapeutics completes NDA submission for taliglucerase alfa

Particle Sciences expands High Potency Compound handling capabilities

AHS annual meeting focuses on myeloma, says IMF

Report on the community-acquired pneumonia drug market

New drug designed to stop cancer from spreading by preventing mitosis

CSC's stem cell-derived motor neuron product for SMA receives FDA orphan drug designation

European markets for Parkinson's disease therapeutics to reach $2.28 billion in 2015

Depression drug TC-5214 earns USF its most lucrative patent royalties to date

Nutrient-rich diet is the best way to stay healthy and reduce risk of chronic diseases

Pharming Group NV's pre-BLA meeting with the FDA for Rhucin

Antithrombotic medication may increase risk of bleeding in dialysis patients undergoing PCI procedure

Most antidepressant medications raise serotonin levels and miss key target of clinical depression

Physicians trust the safety and efficacy of H1N1 vaccine

Researchers find striking disparities in HPV vaccine awareness among low-income population

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News